Fire River Gold Corp. is a near term production company with an experienced technical team focused on bringing its flagship project, the Nixon Fork Gold Mine, back into production in 2011. The Nixon Fork Gold Mine is a fully permitted and bonded mine with past production values averaging 1.14 opt (39 gpt). Facilities at the Nixon Fork Gold Mine include a 200 tpd flotation plant with a gravity gold separation circuit and a sulphide flotation circuit. In 2008, a gold recovery system / CIL gold leaching circuit was purchased and partially installed and is scheduled to be completed by Spring 2011. The mine also includes a fleet of mining vehicles, a self-contained power plant, maintenance facilities, drilling equipment, an 85 person camp, office facilities and a 1.2 km long landing strip.

Fire River Gold Corp is a member of the International Metals Group.

Stock Symbol: FVGCF (PK)

Office: 604-685-1870

Website: http://www.firerivergold.com

NovaGold  is a precious metals company engaged in the exploration and development of mineral properties in North America. NovaGold is focused on advancing its two core properties, Donlin Creek and Galore Creek, with the objective of becoming a low-cost million-ounce-a-year gold producer. When Donlin Creek is in production, NovaGold’s share of production for the first five years is estimated at 800,000 ounces of gold annually, with cash costs in the lower half of the industry. Galore Creek will add additional gold, copper and silver to NovaGold’s annual production.

NovaGold’s management team brings decades of experience in all aspects of exploration, development, finance and project management. Rick Van Nieuwenhuyse, President & CEO, founded NovaGold in 1998 with the objective of creating a mid-tier gold-producing company. NovaGold’s business model focuses on four main steps: Identifying high-quality assets and making strategic, timely acquisitions; using exploration expertise to expand existing deposits; advancing the projects to a feasibility level to bring reserves to the Company and value to shareholders; and creating strong partnerships with well-respected senior producers to advance the projects to production. By systematically executing this four-step business model, NovaGold has three world-class assets in its portfolio, two of which are advancing toward production with senior partnerships in place, and one that provides an exciting exploration opportunity for NovaGold’s team.

With the diversification of three separate multi-million-ounce quality projects at different stages in the production pipeline, NovaGold has one of the strongest production growth profiles in the sector. NovaGold is unhedged and committed to operating to the highest environmental standards at all of its projects. Using industry best practices, we work closely with our local Alaskan Native and First Nations partners to develop projects that provide long-term benefits to those communities, including direct employment and opportunities to build new support-service businesses.

Stock Symbol: NG (AMEX)

Office: 866-669-6227

Website: http://www.novagold.com

Company Profile:

Video1314.com is a subsidiary of IAS ENERGY, INC.
Market Cap: US$11.9 million (as of April 30th,2010)

Video1314.com is one of the fastest growing video Web 2.0 sites in Asia. Video1314.com now serves mostly the greater China area which includes China, Hong Kong, Macau and Taiwan, both on the web and mobile. China Mobile and China Unicom are assisting in the billing to the end users. Video1314.com will now be able to expand its platform to be accessed by mobile phones which are expected to reach 766 million users by 2012.

Stock Symbol: IASCA (OTCQB)

Office: (604) 278-5996

Website: http://www.iasenergy.com/

Company Profile:

BioPharm Asia, Inc. (BioPharm Asia) is an U.S. listed company, primarily engaged in medicine chain business and complemented by a serial industry integrated business including cultivation of Chinese herbal medicine, pharmaceutical production and medicine wholesale.

Starting from 2009, BioPharm Asia has been taking great effort to extend its industry scale in China. By 2011, BioPharm is estimated to complete its chain drugstores sales system establishment, accomplishing with various medicine production capacity, covering Chinese prepared medicines, western medicines, Tibetan medicines and Yi ethnic medicines, and become a large pharmaceutical industry investment group with international integrated marketing capability.

Stock Symbol: BFAR (OTCBB)

Office: (646) 203-3666

Website: http://www.biopharmasiainc.com

Company Profile:

Ocean Bio-Chem, Inc. is a manufacturer and distributor of maintenance and care products for boats, recreational vehicles, automobiles, motorcycles and aircraft. Products are sold under the trademark Star brite™ name to numerous small outlets and also to many national and Canadian retail chains including: Wal-Mart, K-Mart, Home Depot, West Marine, Boater’s World and Boat America.

Stock Symbol: OBCI (Nasdaq)

Ocean Bio-Chem, Inc.
4041 S. W. 47 Avenue
Fort Lauderdale, FL 33314

Office: (954) 587-6280

Website: http://www.oceanbiochem.com

Company Profile:

Artificial Life, Inc. has been a pioneer in artificial intelligence and mobile technology since its inception in Boston in 1994. They are a public US corporation listed on Nasdaq (OTC BB: ALIF) and the Frankfurt Stock Exchange (Frankfurt: AIF.F; Xetra: AIF.DE) with headquarters in Los Angeles. The production center is in Hong Kong and we have additional offices in Berlin, Germany (EMEA headquarters) and Tokyo, Japan.

Recognized internationally for outstanding content quality and technology they have received many international awards and have been ranked one of the fastest growing companies in Asia Pacific by Deloitte.

Stock Symbol: ALIF (OTCBB)

Artificial Life, Inc.
Artificial Life America, Inc.
Santa Monica
United States

Office: (310) 496-4288

Website: http://www.artificial-life.com

Company Profile:

Pro-Dex, Oregon Micro Systems was originally founded in 1980 as Oregon Micro Systems (OMS) and joined the Pro-Dex family in 1995. Motion Control has been at the core of the company from the beginning and several advancements in new products have been produced through that time.

For more than 25 years Pro-Dex OMS has produced superior motion control products including PCI, PC/104, VME bus controls as well as Ethernet and RS232 products. In addition to the standard off the shelf motion control products Pro-Dex OMS produces several custom industrial equipment automation products for specific and often unique automation sustems application.

Pro-Dex OMS can provide off the shelf solutions that in most cases will meet all requirements of the application. However OMS can also customize these device automation controls to the application for the best overall system performance. Pro-Dex OMS is “The Company in Motion” and offers a unique set of motion control products, skills and talented people.

Stock Symbol: PDEX (Nasdaq)

Pro-Dex, Inc.
2361 McGaw Ave
Irvine, California 92614

Office: (949) 769-3200

Website: http://www.omsmotion.com/

Company Profile:

Akorn is a specialty pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products. For more then 60 years, Akorn has been committed to serving our customers by providing an extensive line of affordable, safe and efficacious pharmaceuticals the following markets:

Ophthalmology

Hospital Drugs and Injectables

Akorn’s current product line comprises the following Therapeutic Categories:

• Tetanus and Diphtheria Vaccine

• Tuberculosis Drugs

• Antidotes / Poison Control

• Analgesics / Anesthetics

• Rheumatology

Contract Manufacturing

Akorn operates a contract manufacturing business with the capability and capacity to offer value to pharmaceutical companies looking to outsource manufacturing. Akorn has established contract manufacturing business relationships with large and small pharmaceutical organizations.  Their facilities can manufacture pharmaceuticals that require either aseptic processing or terminal sterilization. Akorn possesses the capability and capacity to manufacture lyophilized products in several therapeutic drug categories.

Stock Symbol: AKRX (Nasdaq)

Akorn, Inc.
1925 West Field Court
Lake Forest, IL 60045

Office: (800) 932-5676

Website: http://www.akorn.com/